NCT02882282 2025-10-23
Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
NRG Oncology
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
Indiana University
Alliance for Clinical Trials in Oncology
Mayo Clinic